We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This strategy sets out Public Health England's 3-year strategic framework.
Details of the process changes for established medicines, effective from 1 March 2024, which apply specifically to chemical products.
This strategy sets out Public Health England's 3-year strategic framework and planned calendar of activity from 2014 to 2017.
An overview of the process including submitting or fast tracking an application, naming your medicine and paying fees.
This strategy sets out our vision of the role of the retail market in achieving net zero.
Use the rolling review route when you want to submit your eCTD dossier in separate parts for pre-assessment instead of making a full consolidated document submission.
Marketing Authorisation Holders should review their manufacturing processes to identify and, if found, to mitigate the risk of nitrosamine impurities being present.
Quality and labelling rules for growing, packing, distributing, importing and selling fresh fruit and vegetables.
Steps to help grow your business - finding finance, mentors, increasing sales and developing products and services
The seeds which must be certified before you can market them, how to get them certified and how to get a licence for your seed business.
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
How the MHRA assesses Marketing Authorisation Applications (MAA) for medicines referred under Article 29.
This guidance covers ‘grandfathering’ and managing the lifecycle changes of medicinal products.
Information for post-16 providers on the next steps towards delivery of T Levels.
Guidance for the pharmaceutical industry on Marketing Authorisations for veterinary medicines.
Business plans - download free templates and get help writing a business plan
How to market, trial and release GMOs.
How to set up a public service mutual and 'spin out' of a public service organisation.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.